SLAMF1/SLAM/CD150 Protein

Quality Statement:
The type I transmembrane glycoprotein Signaling Lymphocytic Activation Molecule (SLAM), also known as CD150, is the prototypic member of the SLAM subgroup of the CD2 protein family. Alternate splicing generates an isoform with a substituted cytoplasmic domain. SLAM is expressed on T cells, B cells, thymocytes, macrophages, dendritic cells, platelets, and hematopoietic stem cells. It is up‑regulated on activated B cells and CD4+ and CD8+ T cells, although it is down‑regulated on Th2 polarized cells. SLAM interacts homophilically with low affinity, and this interaction induces a Th0/Th1 response characterized by clonal expansion, production of IFN-gamma, and increased cytolytic activity of CD8+ T cells. SLAM ligation also promotes B cell activation, allergen-induced eosinophil and mast cell activation, NKT cell development, and the microbicidal response of macrophages to Gram negative bacteria. In humans, SLAM functions as a cellular entry receptor for measles virus.

Reference:
1.Castro, A.G. et al. (1999) J. Immunol. 163:5860.2.Cocks, B.G. et al. (1995) Nature 376:260.3.Wang, N. et al. (2004) J. Exp. Med. 199:1255.4.Hahm, B. et al. (2004) Virology 323:292.5.Nanda, N. et al. (2005) Blood 106:3028.6.Kiel, M.J. et al. (2005) Cell 121:1109.